Neurology

The oral gepant reduced monthly migraine days as well as mean monthly use of migraine rescue medication.

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?

The Alzheimer's Association chief science officer discusses release of updated diagnostic guidelines for AD, which incorporate use of plasma-based biomarkers.

A daily dose of clinical news on Patient Care you may have missed.

A new analysis of the ASPREE trial of aspirin for primary prevention in older adults finds a poor risk-benefit ratio for prevention of stroke.

A majority of older adults agree that all aged ≥65 years should be screened annually for dementia; more than half significantly fear a positive result, the National Poll on Healthy Aging reports.

When is a primary care patient with back pain ready for referral to PM&R? No formulas available but basic principles hold true and earlier is always better.

A daily dose of clinical news you may have missed.

The highest risk of mortality among a Danish population with dementia occurred within 2 weeks of an opioid prescription but remained significant at 180 days.

Regardless of the pattern of physical activity, it may reduce risk across a spectrum of cardiovascular diseases, say study authors. So, just do it!

Disparities in emergency routing persisted despite women being acutely sicker than men and living the same distance from a comprehensive stroke center, in a Houston, Tx study.

Howard Fillit, MD, cofounder/chief scientific officer of the Alzheimer Drug Discovery Foundation, says lecenumab's approval opens the door for future drug development.

Is BMI or body fat a better estimate of obesity?; spoiler: older women do drink ETOH; USPSTF vs ACC/AHA; plus no more opioids for LBP and a primer on migraine meds.

An overview of common headache conditions and treatments for primary care clinicians, here.

Your daily dose of clinical news you may have missed.

FDA's action, based on confirmatory evidence showing slowed disease progression, follows a January 2023 accelerated approval.

Wellbeing is considered a measurable and modifiable community attribute that study authors show is correlated with CV outcomes.

Your daily dose of clinical news you may have missed.

Higher scores on a healthy lifestyle index were associated with significantly reduced risk of incident CVD among women aged 50-79 years with BMI between 18.5 and 25.0.

ENDO 2023. In older men with hypogonadism and CVD, there was no difference in incident CVD between those taking testosterone and those taking placebo.

Your daily dose of clinical news you may have missed.

ENDO 2023: Treatment with bempedoic acid was found comparable to statin therapy in an analysis of the CLEAR Outcomes trial based on CTT Collaboration methodology.

Proposed indications for the investigational factor XIa inhibitor are: stroke prevention after acute ischemic stroke or high-risk transient ischemic attack; recent acute coronary syndrome; and atrial fibrillation.

Your daily dose of clinical news you may have missed.

Results also showed that prediabetes is associated with dementia risk but this risk was explained by the subsequent development of diabetes.